Presentation TCT 2013 Cost-effectiveness of paclitaxel-coated balloon angioplasty for treatment of coronary restenosis in bare-metal stents Presenter: Klaus Bonaventura, Alexander Leber, Christian Sohns, Mattias Roser, Leif-Hendrik Boldt, Wilhelm Haverkamp, Marc Dorenkamp January 31, 2013
Presentation TCT 2013 Biological Efficacy and Vessel Healing of Second Generation Paclitaxel Coated Balloons: A Comparative Study with the original PACCOCATH Technology in the Ilio-Femoral In-Stent... Presenter: Piotr Buszman, Armando Tellez, Maxwell Afari, Jenn McGregor, Yanping Cheng, Gerard Conditt, Serge Rousselle, Greg Kaluza, Juan Granada January 31, 2013
Presentation TCT 2013 Biodegradable-Polymer Biolimus Eluting Stents Show Better Antiproliferative Efficacy And Vascular Healing Pattern Than Permanent-Polymer Paclitaxel Eluting Stents in a Preclinic... Presenter: Armando P?rez de Prado, Claudia P?rez-Mart?nez, Alejandro Diego, Jos? Manuel Gonzalo-Orden, Carlos Cuellas, Marta Regueiro, Beatriz Mart?nez-Fern?ndez, Jose M Ajenjo, Maria J Garcia-Iglesias, Felipe Fern?ndez-V?zquez January 31, 2013
Presentation TCT 2013 Bare-nitinol stent versus paclitaxel-coated balloon for femoro-popliteal revascularization. An adjusted indirect comparison meta-analysis of randomized trials Presenter: Salvatore Cassese, Robert Byrne, Ilka Ott, Tareq Ibrahim, Tomohisa Tada, Lamin King, Adnan Kastrati, Massimiliano Fusaro January 31, 2013
News Daily News La Duración Ideal de la Terapia Antiplaquetaria Doble podría Depender del Tipo de Stent Jason Kahn January 22, 2013
News Daily News Ideal Duration of Dual Antiplatelet Therapy May Depend on Stent Type Jason Kahn January 22, 2013
News Daily News EES Outperform First-Generation DES in Treatment of CTOs L.A. McKeown December 27, 2012
News Daily News Su Publica el PACIFIER: Los Balones liberadores de Fármacos Ayudan a tratar las Lesiones Femoropoplíteas Caitlin E. Cox December 09, 2012
News Daily News PACIFIER Published: Drug-Eluting Balloon Helps Treat Femoropopliteal Lesions Caitlin E. Cox December 09, 2012
Presentation Paclitaxel-Coated Balloons Reduce Restenosis After Femoropopliteal Angioplasty Presenter: Michael Werk December 06, 2012
News Daily News BELLO: Drug-Coated Balloons Take on De Novo Lesions vs. DES Caitlin E. Cox November 15, 2012
News Daily News BELLO: Balones recubiertos de Fármacos contra Lesiones De Novo frente a SLF Caitlin E. Cox November 15, 2012
Presentation BELLO: Paclitaxel Drug-Eluting Balloons vs. Paclitaxel-Eluting Stents in Small Coronary Vessels Presenter: A. Latib November 13, 2012
Presentation TCT 2012 ISAR-DESIRE 3: A Prospective, Randomized Trial of Paclitaxel-Eluting Balloons vs. Paclitaxel-Eluting Stents vs. Balloon Angioplasty for Restenosis of Limus-Eluting Coronary Stents Presenter: Robert Byrne October 26, 2012
Presentation TCT 2012 Paclitaxel Delivery and Tissue Effects: Similarities and Critical Differences with DES Presenter: Renu Virmani October 25, 2012
Presentation TCT 2012 Impact of Paclitaxel Formulation on Drug Transfer, Tissue Pharmacokinetics, and Biological Activity Presenter: Juan Granada October 25, 2012
Presentation TCT 2012 DEBATE-BTK: A Prospective, Randomized Trial of Paclitaxel Coated Balloon Angioplasty in Diabetic Patients with Critical Limb Ischemia Undergoing Angioplasty of Below-the-Knee... Presenter: Francesco Liistro October 25, 2012
Presentation TCT 2012 TCT-70. Comparison of Efficacy and Safety Between Sirolimus, Paclitaxel, Everolimus-eluting Stent and SeQuent™ Please, a Drug-eluting Balloon on the Outcome of Patients with... Presenter: Sunao Nakamura October 23, 2012